Metabolic profiling for the diagnosis of ASD phenotype 1, a subset of patients with idiopathic autism spectrum disorders

摘要

【wrap up】 The present invention is to assess the energy-producing capacity of patient-specific cell lines in the presence of various carbon energy sources and metabolic factors, or to have no change or change in energy-producing capacity after administration of Nrf2 inhibitors. The present invention relates to a method for diagnosing a subtype of autism spectrum disorder (ASD), so-called ASD phenotype 1, by evaluating. [Selection diagram] None